|
1
|
Pickens A and Orringer MB: Geographical
distribution and racial disparity in esophageal cancer. Ann Thorac
Surg. 76:S1367–S1369. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang J, Jiang Y, Wu C, Cai S, Wang R,
Zhen Y, Chen S, Zhao K, Huang Y, Luketich J and Chen H: Comparison
of clinicopathologic features and survival between eastern and
western population with esophageal squamous cell carcinoma. J
Thorac Dis. 7:1780–1786. 2015.PubMed/NCBI
|
|
3
|
Cui Z, Tian Y, He B, Li H, Li D, Liu J,
Cai H, Lou J, Jiang H, Shen X and Peng K: Associated factors of
radiation pneumonitis induced by precise radiotherapy in 186
elderly patients with esophageal cancer. Int J Clin Exp Med.
8:16646–16651. 2015.PubMed/NCBI
|
|
4
|
Nasr JY and Schoen RE: Prevalence of
adenocarcinoma at esophagectomy for Barrett's esophagus with high
grade dysplasia. J Gastrointest Oncol. 2:34–38. 2011.PubMed/NCBI
|
|
5
|
Wagner TD, Khushalani N and Yang GY:
Clinical T2N0M0 carcinoma of thoracic esophagus. J Thorac Dis.
2:36–42. 2010.PubMed/NCBI
|
|
6
|
Jabbour SK and Thomas CR Jr: Radiation
therapy in the postoperative management of esophageal cancer. J
Gastrointest Oncol. 1:102–111. 2010.PubMed/NCBI
|
|
7
|
Das P: Esophageal cancer: Is preoperative
chemoradiation the new standard? J Gastrointest Oncol. 1:68–69.
2010.PubMed/NCBI
|
|
8
|
Kleinberg L: Does postoperative radiation
therapy benefit patients with esophageal cancer? J Gastrointest
Oncol. 1:70–71. 2010.PubMed/NCBI
|
|
9
|
Prasanna PG, Stone HB, Wong RS, Capala J,
Bernhard EJ, Vikram B and Coleman CN: Normal tissue protection for
improving radiotherapy: Where are the gaps? Transl Cancer Res.
1:35–48. 2012.PubMed/NCBI
|
|
10
|
Sun GP, Wan X, Xu SP, Wang H, Liu SH and
Wang ZG: Antiproliferation and apoptosis induction of paeonol in
human esophageal cancer cell lines. Dis Esophagus. 21:723–729.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu C, Fan S, Sun Y and Pickwell-Macpherson
E: The potential of terahertz imaging for cancer diagnosis: A
review of investigations to date. Quant Imaging Med Surg. 2:33–45.
2012.PubMed/NCBI
|
|
12
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:pp. 15077–15082. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang W, Choi W, Hu W, Mi N, Guo Q, Ma M,
Liu M, Tian Y, Lu P, Wang FL, et al: Crystal structure and
biochemical analyses reveal Beclin 1 as a novel membrane binding
protein. Cell Res. 22:473–489. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang MC, Wang HC, Hou YC, Tung HL, Chiu TJ
and Shan YS: Blockade of autophagy reduces pancreatic cancer stem
cell activity and potentiates the tumoricidal effect of
gemcitabine. Mol Cancer. 14:1792015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Talsma K, van Hagen P, Grotenhuis BA,
Steyerberg EW, Tilanus HW, van Lanschot JJ and Wijnhoven BP:
Comparison of the 6th and 7th editions of the UICC-AJCC TNM
classification for esophageal cancer. Ann Surg Oncol. 19:2142–2148.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Du H, Yang W, Chen L, Shen B, Peng C, Li
H, Ann DK, Yen Y and Qiu W: Emerging role of autophagy during
ischemia-hypoxia and reperfusion in hepatocellular carcinoma. Int J
Oncol. 40:2049–2057. 2012.PubMed/NCBI
|
|
17
|
Fiorini C, Cordani M, Gotte G, Picone D
and Donadelli M: Onconase induces autophagy sensitizing pancreatic
cancer cells to gemcitabine and activates Akt/mTOR pathway in a
ROS-dependent manner. Biochim Biophys Acta. 1853:549–560. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li BX, Li CY, Peng RQ, Wu XJ, Wang HY, Wan
DS, Zhu XF and Zhang XS: The expression of beclin 1 is associated
with favorable prognosis in stage IIIB colon cancers. Autophagy.
5:303–306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai
Z, Shi GM, Wang XY, Ke AW, Wu B and Fan J: Association of autophagy
defect with a malignant phenotype and poor prognosis of
hepatocellular carcinoma. Cancer Res. 68:9167–9175. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koneri K, Goi T, Hirono Y, Katayama K and
Yamaguchi A: Beclin 1 gene inhibits tumor growth in colon cancer
cell lines. Anticancer Res. 27:1453–1457. 2007.PubMed/NCBI
|
|
23
|
Toton E, Lisiak N, Sawicka P and
Rybczynska M: Beclin-1 and its role as a target for anticancer
therapy. J Physiol Pharmacol. 65:459–467. 2014.PubMed/NCBI
|
|
24
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al:
Promotion of tumorigenesis by heterozygous disruption of the beclin
1 autophagy gene. J Clin Invest. 112:1809–1820. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Burada F, Nicoli ER, Ciurea ME, Uscatu DC,
Ioana M and Gheonea DI: Autophagy in colorectal cancer: An
important switch from physiology to pathology. World J Gastrointest
Oncol. 7:271–284. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Teng RJ, Du J, Welak S, Guan T, Eis A, Shi
Y and Konduri GG: Cross talk between NADPH oxidase and autophagy in
pulmonary artery endothelial cells with intrauterine persistent
pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol.
302:L651–L663. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee SJ, Kim HP, Jin Y, Choi AM and Ryter
SW: Beclin 1 deficiency is associated with increased
hypoxia-induced angiogenesis. Autophagy. 7:829–839. 2011.
View Article : Google Scholar : PubMed/NCBI
|
